HKEX Filings
- 
					Mar 31, 2022
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME
 - 
					Mar 29, 2022
PROPOSED ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
 - 
					Mar 29, 2022
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
 - 
					Mar 18, 2022
CLARIFICATION ANNOUNCEMENT
 - 
					Mar 17, 2022
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 VACCINE CANDIDATE DEMONSTRATED DURABLE HIGH PROTECTION AND STRONG IMMUNE RESPONSE AGAINST OMICRON AS A BOOSTER
 - 
					Mar 17, 2022
DATE OF BOARD MEETING
 - 
					Mar 11, 2022
CHANGE OF ADDRESS OF HEADQUARTERS IN THE PRC
 - 
					Mar 4, 2022
Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2022
 - 
					Feb 24, 2022
VOLUNTARY ANNOUNCEMENT - INCLUSION ON THE HANG SENG COMPOSITE INDEX
 - 
					Feb 14, 2022
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE
 - 
					Feb 7, 2022
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2022
 - 
					Jan 28, 2022
WAIVER FROM STRICT COMPLIANCE WITH RULE 10.07(1)(B) OF THE LISTING RULES
 - 
					Jan 21, 2022
VOLUNTARY ANNOUNCEMENT - PUBLICATION IN THE LANCET SHOWING THAT SCB-2019 (CPG 1018/ALUM) IN A PHASE 2/3 CLINICAL TRIAL DEMONSTRATES EFFICACY AGAINST ENTIRE SEVERITY SPECTRUM OF COVID-19
 - 
					Jan 6, 2022
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2021
 - 
					Jan 5, 2022
VOLUNTARY ANNOUNCEMENT - DOSING OF FIRST PARTICIPANTS WITH HOMOLOGOUS BOOSTER DOSE OF COVID-19 VACCINE CANDIDATE IN SPECTRA
 - 
					Dec 22, 2021
CHANGE OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
 - 
					Dec 9, 2021
VOLUNTARY ANNOUNCEMENT - COLLABORATION AGREEMENT WITH ASCENTAGE PHARMA
 - 
					Dec 7, 2021
VOLUNTARY ANNOUNCEMENT - ENTERING INTO THE VACCINE SUPPLY AGREEMENT
 - 
					Dec 6, 2021
Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2021
 - 
					Nov 29, 2021
STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF OVER-ALLOTMENT OPTION
 



